{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T03:26:05Z","timestamp":1792553165031,"version":"4.5.0"},"reference-count":93,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T00:00:00Z","timestamp":1699401600000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.ccell.2023.10.006","type":"journal-article","created":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T14:31:29Z","timestamp":1698935489000},"page":"1972-1988.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"title":["Anti-PD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic castration-sensitive prostate cancer"],"prefix":"10.1016","volume":"41","author":[{"given":"Jessica E.","family":"Hawley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandar Z.","family":"Obradovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew C.","family":"Dallos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emerson A.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karie","family":"Runcie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casey R.","family":"Ager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"McKiernan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher B.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guarionex J.","family":"Decastro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Weintraub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renu","family":"Virk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israel","family":"Lowy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew G.","family":"Chaimowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinzheng V.","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Haffner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Worley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark N.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Califano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles G.","family":"Drake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccell.2023.10.006_bib1","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/s41391-021-00340-5","article-title":"How to turn up the heat on the cold immune microenvironment of metastatic prostate cancer","volume":"24","author":"Stultz","year":"2021","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.ccell.2023.10.006_bib2","doi-asserted-by":"crossref","first-page":"6764","DOI":"10.1158\/1078-0432.CCR-17-0019","article-title":"Immunotherapy of Prostate Cancer: Facts and Hopes","volume":"23","author":"Bilusic","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2023.10.006_bib3","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1084\/jem.20042028","article-title":"Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers","volume":"201","author":"Bronte","year":"2005","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccell.2023.10.006_bib4","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1002\/pros.21020","article-title":"Human prostate-infiltrating CD8+ T lymphocytes are oligoclonal and PD-1+","volume":"69","author":"Sfanos","year":"2009","journal-title":"Prostate"},{"key":"10.1016\/j.ccell.2023.10.006_bib5","article-title":"Single-Cell proteomics defines the cellular heterogeneity of localized prostate cancer","author":"Vargas Roditi","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.ccell.2023.10.006_bib6","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1158\/1078-0432.CCR-19-3372","article-title":"T-cell infiltration and adaptive treg resistance in response to androgen deprivation with or without vaccination in localized prostate cancer","volume":"26","author":"Obradovic","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2023.10.006_bib7","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ccr.2005.01.027","article-title":"Androgen ablation mitigates tolerance to a prostate\/prostate cancer-restricted antigen","volume":"7","author":"Drake","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2023.10.006_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jim.2009.06.004","article-title":"Characterization of the intra-prostatic immune cell infiltration in androgen-deprived prostate cancer patients","volume":"348","author":"Gannon","year":"2009","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.ccell.2023.10.006_bib9","doi-asserted-by":"crossref","first-page":"14565","DOI":"10.1073\/pnas.251140998","article-title":"T cell infiltration of the prostate induced by androgen withdrawal in patients with prostate cancer","volume":"98","author":"Mercader","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2023.10.006_bib10","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.4049\/jimmunol.175.4.2741","article-title":"Activation of thymic regeneration in mice and humans following androgen blockade","volume":"175","author":"Sutherland","year":"2005","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ccell.2023.10.006_bib11","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ccr.2005.01.027","article-title":"Androgen ablation mitigates tolerance to a prostate\/prostate cancer-restricted antigen","volume":"7","author":"Drake","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2023.10.006_bib12","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.humimm.2010.02.007","article-title":"Prostate cancer patients on androgen deprivation therapy develop persistent changes in adaptive immune responses","volume":"71","author":"Morse","year":"2010","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.ccell.2023.10.006_bib13","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41391-017-0013-x","article-title":"Combining intratumoral Treg depletion with androgen deprivation therapy (ADT): preclinical activity in the Myc-CaP model","volume":"21","author":"Shen","year":"2018","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.ccell.2023.10.006_bib14","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1677\/joe.0.1100417","article-title":"Reappearance of the thymus in old rats after orchidectomy: inhibition of regeneration by testosterone","volume":"110","author":"Greenstein","year":"1986","journal-title":"J.\u00a0Endocrinol."},{"key":"10.1016\/j.ccell.2023.10.006_bib15","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1677\/joe.0.1120345","article-title":"Regeneration of the thymus in old male rats treated with a stable analogue of LHRH","volume":"112","author":"Greenstein","year":"1987","journal-title":"J.\u00a0Endocrinol."},{"key":"10.1016\/j.ccell.2023.10.006_bib16","doi-asserted-by":"crossref","first-page":"6098","DOI":"10.4049\/jimmunol.173.10.6098","article-title":"Augmentation of T\u00a0cell levels and responses induced by androgen deprivation","volume":"173","author":"Roden","year":"2004","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ccell.2023.10.006_bib17","doi-asserted-by":"crossref","first-page":"9887","DOI":"10.1073\/pnas.1402468111","article-title":"Androgens alter T-cell immunity by inhibiting T-helper 1 differentiation","volume":"111","author":"Kissick","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2023.10.006_bib18","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1182\/blood.V85.6.1535.bloodjournal8561535","article-title":"Enhanced production of B lymphocytes after castration","volume":"85","author":"Wilson","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2023.10.006_bib19","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0040-8166(98)80011-6","article-title":"Effects of castration on the lymphocytes of the thymus, spleen and lymph nodes","volume":"30","author":"Windmill","year":"1998","journal-title":"Tissue Cell"},{"key":"10.1016\/j.ccell.2023.10.006_bib20","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1158\/1078-0432.CCR-10-2804","article-title":"Androgen deprivation boosts prostatic infiltration of cytotoxic and regulatory T lymphocytes and has no effect on disease-free survival in prostate cancer patients","volume":"17","author":"Sorrentino","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2023.10.006_bib21","doi-asserted-by":"crossref","first-page":"333ra47","DOI":"10.1126\/scitranslmed.aad5659","article-title":"Androgen receptor antagonists compromise T\u00a0cell response against prostate cancer leading to early tumor relapse","volume":"8","author":"Pu","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ccell.2023.10.006_bib22","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1158\/0008-5472.CAN-11-2499","article-title":"Increased CD8+ T-cell function following castration and immunization is countered by parallel expansion of regulatory T\u00a0cells","volume":"72","author":"Tang","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2023.10.006_bib23","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.ajpath.2018.02.014","article-title":"Comprehensive Evaluation of Programmed Death-Ligand 1 Expression in Primary and Metastatic Prostate Cancer","volume":"188","author":"Haffner","year":"2018","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ccell.2023.10.006_bib24","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1038\/s41467-021-21615-4","article-title":"Inter- and intra-tumor heterogeneity of metastatic prostate cancer determined by digital spatial gene expression profiling","volume":"12","author":"Brady","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2023.10.006_bib25","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41591-021-01244-6","article-title":"Transcriptional mediators of treatment resistance in lethal prostate cancer","volume":"27","author":"He","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2023.10.006_bib26","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1038\/s41467-018-03843-3","article-title":"Quantitative assessment of protein activity in orphan tissues and single cells using the metaVIPER algorithm","volume":"9","author":"Ding","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2023.10.006_bib27","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/ng.3593","article-title":"Functional characterization of somatic mutations in cancer using network-based inference of protein activity","volume":"48","author":"Alvarez","year":"2016","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ccell.2023.10.006_bib28","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1016\/j.cell.2021.04.038","article-title":"Single-cell protein activity analysis identifies recurrence-associated renal tumor macrophages","volume":"184","author":"Obradovic","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2023.10.006_bib29","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/s41588-018-0138-4","article-title":"A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors","volume":"50","author":"Alvarez","year":"2018","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ccell.2023.10.006_bib30","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","article-title":"Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage","volume":"20","author":"Aran","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ccell.2023.10.006_bib31","first-page":"281","article-title":"Mass cytometry reveals species-specific differences and a new level of complexity for immune cells in the prostate","volume":"7","author":"Fox","year":"2019","journal-title":"Am. J. Clin. Exp. Urol."},{"key":"10.1016\/j.ccell.2023.10.006_bib32","doi-asserted-by":"crossref","first-page":"34342","DOI":"10.1074\/jbc.M109.042671","article-title":"CCL2 and interleukin-6 promote survival of human CD11b+ peripheral blood mononuclear cells and induce M2-type macrophage polarization","volume":"284","author":"Roca","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ccell.2023.10.006_bib33","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13059-020-02048-6","article-title":"Systematic assessment of tissue dissociation and storage biases in single-cell and single-nucleus RNA-seq workflows","volume":"21","author":"Denisenko","year":"2020","journal-title":"Genome Biol."},{"key":"10.1016\/j.ccell.2023.10.006_bib34","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3389\/fimmu.2018.00070","article-title":"Tissue-dependent tumor microenvironments and their impact on immunotherapy responses","volume":"9","author":"Oliver","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ccell.2023.10.006_bib35","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2023.10.006_bib36","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1073\/pnas.1913054117","article-title":"Structure and regulation of human epithelial cell transforming 2 protein","volume":"117","author":"Chen","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2023.10.006_bib37","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1158\/0008-5472.CAN-15-2923","article-title":"Rho GTPase Transcriptome Analysis Reveals Oncogenic Roles for Rho GTPase-activating Proteins in Basal-like Breast Cancers","volume":"76","author":"Lawson","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2023.10.006_bib38","doi-asserted-by":"crossref","first-page":"45459","DOI":"10.18632\/oncotarget.17564","article-title":"Overexpression of a novel candidate oncogene KIF14 correlates with tumor progression and poor prognosis in prostate cancer","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ccell.2023.10.006_bib39","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nrurol.2009.127","article-title":"ETS gene fusions in prostate cancer","volume":"6","author":"Clark","year":"2009","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.ccell.2023.10.006_bib40","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1038\/sj.onc.1208518","article-title":"Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome","volume":"24","author":"Petrovics","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.ccell.2023.10.006_bib41","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41556-020-00613-6","article-title":"Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression","volume":"23","author":"Chen","year":"2021","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ccell.2023.10.006_bib42","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1084\/jem.171.5.1393","article-title":"LAG-3, a novel lymphocyte activation gene closely related to CD4","volume":"171","author":"Triebel","year":"1990","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccell.2023.10.006_bib43","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/1878-0261.13158","article-title":"Clinical and biological relevance of the transcriptomic-based prostate cancer metastasis subtypes MetA-C","volume":"16","author":"Thysell","year":"2022","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.ccell.2023.10.006_bib44","doi-asserted-by":"crossref","first-page":"375","DOI":"10.4049\/jimmunol.1701044","article-title":"Inhibitors of the PD-1 Pathway in Tumor Therapy","volume":"200","author":"LaFleur","year":"2018","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ccell.2023.10.006_bib45","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10555-006-9005-3","article-title":"TNF-alpha in promotion and progression of cancer","volume":"25","author":"Balkwill","year":"2006","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.ccell.2023.10.006_bib46","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.3389\/fimmu.2019.01818","article-title":"The TNF Paradox in Cancer Progression and Immunotherapy","volume":"10","author":"Montfort","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ccell.2023.10.006_bib47","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/s41586-019-1162-y","article-title":"Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy","volume":"569","author":"Perez-Ruiz","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2023.10.006_bib48","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1002\/pros.23881","article-title":"Genomic and clinical characterization of pulmonary-only metastatic prostate cancer: A unique molecular subtype","volume":"79","author":"Shenderov","year":"2019","journal-title":"Prostate"},{"key":"10.1016\/j.ccell.2023.10.006_bib49","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1006\/geno.1997.4715","article-title":"A Novel Human Prostate-Specific, Androgen-Regulated Homeobox Gene (NKX3.1) That Maps to 8p21, a Region Frequently Deleted in Prostate Cancer","volume":"43","author":"He","year":"1997","journal-title":"Genomics"},{"key":"10.1016\/j.ccell.2023.10.006_bib50","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1210\/me.2013-1098","article-title":"Androgen Regulation of the TMPRSS2 Gene and the Effect of a SNP in an Androgen Response Element","volume":"27","author":"Clinckemalie","year":"2013","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.ccell.2023.10.006_bib51","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1126\/science.1117679","article-title":"Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer","volume":"310","author":"Tomlins","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.ccell.2023.10.006_bib52","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.cell.2015.05.001","article-title":"Integrative clinical genomics of advanced prostate cancer","volume":"161","author":"Robinson","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2023.10.006_bib53","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.cell.2018.06.039","article-title":"Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer","volume":"174","author":"Quigley","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2023.10.006_bib54","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/s42003-020-01476-1","article-title":"Single-cell analysis supports a luminal-neuroendocrine transdifferentiation in human prostate cancer","volume":"3","author":"Dong","year":"2020","journal-title":"Commun. Biol."},{"key":"10.1016\/j.ccell.2023.10.006_bib55","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1126\/science.aay0267","article-title":"Regenerative potential of prostate luminal cells revealed by single-cell analysis","volume":"368","author":"Karthaus","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ccell.2023.10.006_bib56","article-title":"Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell states","author":"Song","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.ccell.2023.10.006_bib57","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41585-020-00400-w","article-title":"Genomic and phenotypic heterogeneity in prostate cancer","volume":"18","author":"Haffner","year":"2021","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.ccell.2023.10.006_bib58","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.ccell.2021.09.005","article-title":"Human prostate cancer bone metastases have an actionable immunosuppressive microenvironment","volume":"39","author":"Kfoury","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2023.10.006_bib59","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nm.4045","article-title":"Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer","volume":"22","author":"Beltran","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2023.10.006_bib60","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ccell.2017.09.003","article-title":"Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling","volume":"32","author":"Bluemn","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2023.10.006_bib61","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.1172\/JCI128212","article-title":"Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer","volume":"129","author":"Labrecque","year":"2019","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ccell.2023.10.006_bib62","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41591-021-01600-6","article-title":"Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trial","volume":"28","author":"Powles","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2023.10.006_bib63","article-title":"Merck Announces KEYNOTE-991 Trial Evaluating KEYTRUDA\u00ae (pembrolizumab) Plus Enzalutamide and Androgen Deprivation Therapy\u00a0in Patients With Metastatic Hormone-Sensitive Prostate Cancer to Stop for Futility -","year":"2023","journal-title":"Merck.com."},{"key":"10.1016\/j.ccell.2023.10.006_bib64","doi-asserted-by":"crossref","first-page":"6659","DOI":"10.4049\/jimmunol.0804211","article-title":"Functionally Distinct LAG-3 and PD-1 Subsets on Activated and Chronically Stimulated CD8\u00a0T Cells","volume":"182","author":"Grosso","year":"2009","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ccell.2023.10.006_bib65","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.soc.2007.07.009","article-title":"Current immunotherapeutic strategies in prostate cancer","volume":"16","author":"Grosso","year":"2007","journal-title":"Surg. Oncol. Clin."},{"key":"10.1016\/j.ccell.2023.10.006_bib66","doi-asserted-by":"crossref","first-page":"9503","DOI":"10.1200\/JCO.2021.39.15_suppl.9503","article-title":"Relatlimab (RELA) plus nivolumab (NIVO) versus NIVO in first-line advanced melanoma: Primary phase III results from RELATIVITY-047 (CA224-047)","volume":"39","author":"Lipson","year":"2021","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ccell.2023.10.006_bib67","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1912892","article-title":"PD-1 and LAG-3 blockade improve anti-tumor vaccine efficacy","volume":"10","author":"Zahm","year":"2021","journal-title":"OncoImmunology"},{"key":"10.1016\/j.ccell.2023.10.006_bib68","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1200\/EDBK_240837","article-title":"Mechanisms of Resistance to Immune Checkpoint Blockade: Why Does Checkpoint Inhibitor Immunotherapy Not Work for All Patients?","author":"Fares","year":"2019","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.ccell.2023.10.006_bib69","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/s41591-019-0420-8","article-title":"Rational design of anti-GITR-based combination immunotherapy","volume":"25","author":"Zappasodi","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2023.10.006_bib70","doi-asserted-by":"crossref","first-page":"6501","DOI":"10.1158\/1078-0432.CCR-19-0289","article-title":"Characterization and Comparison of GITR Expression in Solid Tumors","volume":"25","author":"Vence","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2023.10.006_bib71","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1001\/jamaoncol.2019.3848","volume":"6","author":"Heinhuis","year":"2020","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.ccell.2023.10.006_bib72","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s40425-018-0407-x","article-title":"Dose escalation results from a first-in-human, phase 1 study of glucocorticoid-induced TNF receptor\u2013related protein agonist AMG 228 in patients with advanced solid tumors","volume":"6","author":"Tran","year":"2018","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.ccell.2023.10.006_bib73","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41571-019-0221-5","article-title":"GITR agonism \u2014 combination is key","volume":"16","author":"Killock","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ccell.2023.10.006_bib74","doi-asserted-by":"crossref","first-page":"4926","DOI":"10.1002\/cncr.33133","article-title":"First-in-human phase 1 study of MK-1248, an anti-glucocorticoid-induced tumor necrosis factor receptor agonist monoclonal antibody, as monotherapy or with pembrolizumab in patients with advanced solid tumors","volume":"126","author":"Geva","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.ccell.2023.10.006_bib75","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nrc2628","article-title":"Tumour necrosis factor and cancer","volume":"9","author":"Balkwill","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccell.2023.10.006_bib76","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/pros.23948","article-title":"Association between immunosuppressive cytokines and PSA progression in biochemically recurrent prostate cancer treated with intermittent hormonal therapy","volume":"80","author":"Hawley","year":"2020","journal-title":"Prostate"},{"key":"10.1016\/j.ccell.2023.10.006_bib77","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/pros.22788","article-title":"Elevated IL-8, TNF-alpha, and MCP-1 in men with metastatic prostate cancer starting androgen-deprivation therapy (ADT) are associated with shorter time to castration-resistance and overall survival","volume":"74","author":"Sharma","year":"2014","journal-title":"Prostate"},{"key":"10.1016\/j.ccell.2023.10.006_bib78","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1038\/sj.bjc.6601814","article-title":"Serum levels of IL-6 and TNF-\u03b1 correlate with clinicopathological features and patient survival in patients with prostate cancer","volume":"90","author":"Michalaki","year":"2004","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ccell.2023.10.006_bib79","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1111\/cas.13586","article-title":"Tumor necrosis factor-\u03b1 induces prostate cancer cell migration in lymphatic metastasis through CCR7 upregulation","volume":"109","author":"Maolake","year":"2018","journal-title":"Cancer Sci."},{"key":"10.1016\/j.ccell.2023.10.006_bib80","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10495-009-0416-9","article-title":"Inhibiting TNF-mediated signaling: A novel therapeutic paradigm for androgen independent prostate cancer","volume":"15","author":"Srinivasan","year":"2010","journal-title":"Apoptosis"},{"key":"10.1016\/j.ccell.2023.10.006_bib81","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1158\/2326-6066.CIR-20-0637","article-title":"Longitudinal immune profiling reveals unique myeloid and T-cell phenotypes associated with spontaneous immunoediting in a prostate tumor model","volume":"9","author":"Ager","year":"2021","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.ccell.2023.10.006_bib82","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2023.10.006_bib83","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","article-title":"Comprehensive Integration of Single-Cell Data","volume":"177","author":"Stuart","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2023.10.006_bib84","unstructured":"Tickle T, Tirosh I, Georgescu C, Brown M, Haas B (2019). inferCNV of the Trinity CTAT Project.. Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA. https:\/\/github.com\/broadinstitute\/inferCNV.Infer Copy Number Variation from Single-Cell RNA-Seq Data 2018. https:\/\/bioconductor.org\/packages\/release\/bioc\/html\/infercnv.html."},{"key":"10.1016\/j.ccell.2023.10.006_bib85","doi-asserted-by":"crossref","unstructured":"Lachmann A., Federico M. Giorgi, Lopez G., Califano A. (2016). ARACNe-AP: gene network reverse engineering through adaptive partitioning inference of mutual information. Bioinformatics 32: 2233\u20132235.","DOI":"10.1093\/bioinformatics\/btw216"},{"key":"10.1016\/j.ccell.2023.10.006_bib86","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1056\/NEJMoa1503747","article-title":"Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer","volume":"373","author":"Sweeney","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2023.10.006_bib87","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1200\/JCO.1996.14.1.296","article-title":"New statistical strategy for monitoring safety and efficacy in single-arm clinical trials","volume":"14","author":"Thall","year":"1996","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ccell.2023.10.006_bib88","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.3324\/haematol.2013.094243","article-title":"BLUEPRINT: Mapping human blood cell epigenomes","volume":"98","author":"Martens","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.ccell.2023.10.006_bib89","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature11247","article-title":"An integrated encyclopedia of DNA elements in the human genome","volume":"489","author":"Kundaje","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2023.10.006_bib90","article-title":"PISCES: A pipeline for the Systematic, Protein Activity-based Analysis of Single Cell RNA Sequencing Data","author":"Obradovic","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.ccell.2023.10.006_bib91","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1471-2105-14-128","article-title":"Enrichr: Interactive and collaborative HTML5 gene list enrichment analysis tool","volume":"14","author":"Chen","year":"2013","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.ccell.2023.10.006_bib92","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.cell.2015.10.025","article-title":"The Molecular Taxonomy of Primary Prostate Cancer","volume":"163","author":"Ahn","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2023.10.006_bib93","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ccell.2022.03.006","article-title":"Neoantigen-specific CD4+ T\u00a0cells in human melanoma have diverse differentiation states and correlate with CD8+ T\u00a0cell, macrophage, and B cell function","volume":"40","author":"Veatch","year":"2022","journal-title":"Cancer Cell"}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610823003628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610823003628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T05:08:09Z","timestamp":1733807289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535610823003628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":93,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S1535610823003628"],"URL":"https:\/\/doi.org\/10.1016\/j.ccell.2023.10.006","relation":{},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-PD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic castration-sensitive prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccell.2023.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}